VIGONVITA-B (02630.HK): pre-IPO investors voluntarily extend lock-up by 4-7 months

NewTimeSpace News: According to the HKEX on October 30, Vigonvita Life Sciences Co., Ltd. ("Vigonvita", 02630.HK) announced that it has received notices from all pre-IPO investors, including the controlling shareholder, who each undertake to extend their lock-up period by seven months or four months from the expiry of the original lock-up, based on their recognition of the company's R&D pipeline value and commercialization prospects.

According to the announcement, controlling shareholder Dr. Shen Jingshan (holding 82,461,110 shares) and his spouse Ms. Jin Jie (2,272,478 shares) undertake not to reduce their holdings until June 6, 2027 (inclusive); nine individual shareholders including Dr. Tian Guanghui, Ms. Jin Qing and Dr. Hu Tianwen, together with the employee incentive platform Suzhou Hesheng Enterprise Management Consulting Partnership (Limited Partnership), undertake to extend until March 6, 2027 (inclusive); 17 institutional shareholders including Ganzhou Yufeishanshui Equity Investment, Gongqingcheng Zhongcai Qihoo II, Suzhou Xieyao Kexin Venture Capital and Jiaxing Yuhan Equity Investment also undertake to extend until March 6, 2027 (inclusive).

The company said the extension demonstrates these shareholders' confidence in its future prospects and long-term value. Under the prospectus and allotment results announcement, the original lock-up period for all pre-IPO investors, including the controlling shareholder, expires on November 5, 2026.